Astrazeneca Pharma India Ltd

Astrazeneca Pharma India Ltd

Next 500 2022
+ 3 More
+ 3 More
OVERVIEW
FINANCIALS

Featured In Fortune India Ranking

Next 500 India
#337(2022)#306(2021)#437(2020)#449(2019)
#337(2022)#306(2021)#437(2020)#449(2019)
Ranking Trend Fortune Next 500 India

Financial Data 2024

Revenue
1,381
(INR Cr)
Net Operating Income
1,296
(INR Cr)
Assets
723
(INR Cr)
Profit
162
(INR Cr)
Net Worth
712
(INR Cr)

Financial Data

RevenueNet Operating IncomeProfitAssetsNet Worth
PARAMETERS2024202320222021202020192018201720162015201420132012201120092008
Revenue
(INR Cr)
1381
28.1%
1078
33.8%
806
-2.1%
823
-6.9%
884
18.5%
746
17.6%
634
17.4%
540
-4.4%
565
9.3%
517
0.0%
517
27.9%
404
-26.5%
550
-10.4%
614
52.1%
404
6.5%
379
-
Net Operating Income
(INR Cr)
1296
29.17%
1003
24.50%
806
-0.98%
814
-2.19%
832
14.21%
728
27.55%
571
5.02%
544
-3.55%
564
9.02%
517
9.09%
474
21.40%
390
-26.55%
532
-10.56%
594
49.81%
397
12.18%
354
16.83%
Profit
(INR Cr)
162
62.7%
99
61.2%
62
-34.0%
93
29.2%
72
32.6%
54
110.2%
26
29.2%
20
281.2%
5
-
-21
-
-1
-
-90
-
20
-69.2%
64
11.3%
58
-22.0%
74
-
Assets
(INR Cr)
723
19.6%
604
14.6%
528
11.1%
475
24.4%
382
26.0%
303
19.4%
254
12.6%
225
33.3%
169
11.3%
152
-11.8%
172
71.7%
100
-47.2%
190
3.6%
183
26.8%
145
-19.1%
179
-
Net Worth
(INR Cr)
712
20.9%
589
15.1%
511
12.1%
456
25.2%
364
21.2%
301
21.8%
247
10.8%
223
42.9%
156
3.5%
151
-12.1%
172
72.0%
100
-47.3%
189
5.3%
180
24.3%
145
24.4%
116
-27.1%
Employee Cost
(INR Cr)
241
-6.8%
259
12.6%
230
4.9%
220
1.3%
217
9.8%
197
31.3%
150
-7.2%
162
-4.3%
169
6.0%
160
-0.4%
160
8.1%
148
-8.3%
162
7.6%
151
85.1%
81
33.8%
61
-
Interest Cost
(INR Cr)
1111100000000005
Cash & Bank Balance
(INR Cr)
50650044835225317312611677258918538568144
Total Debt
(INR Cr)
5791212000000000063

Key Financial Ratios

Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
PARAMETERS2024202320222021202020192018201720162015201420132012201120092008
Profit As % Of Revenues 11.7%9.2%7.6%11.3%8.2%7.3%4.1%3.7%0.9%---3.6%10.5%14.3%19.5%
Profit As % Of Assets 22.4%16.4%11.7%19.7%18.9%18.0%10.2%8.9%3.1%---10.4%35.0%39.9%41.3%
Profit As % Of Networth 22.7%16.9%12.1%20.5%19.8%18.1%10.5%9.0%3.4%---10.4%35.7%39.9%63.6%
Interest Cost to EBITDA % 0.7%0.5%1.1%0.8%0.9%---------0.2%4.3%
Debt to Equity Ratio 0.010.010.020.030.03----------0.54
RONW 24.8%23.0%12.7%22.7%21.7%19.9%11.0%8.3%3.4%---10.7%31.7%44.2%53.6%
ROCE 33.3%30.5%16.8%29.9%33.6%26.1%18.3%14.2%3.6%-12.9%-12.1%-48.5%15.7%47.9%54.8%70.6%